Cassandra Szoeke
#92,591
Most Influential Person Now
Australian medical researcher
Cassandra Szoeke's AcademicInfluence.com Rankings
Cassandra Szoekelaw Degrees
Law
#3090
World Rank
#3881
Historical Rank
Common Law
#184
World Rank
#200
Historical Rank
International Law
#1140
World Rank
#1371
Historical Rank
Download Badge
Law
Cassandra Szoeke's Degrees
- Bachelors Biomedical Science University of Melbourne
- PhD Medicine Monash University
Why Is Cassandra Szoeke Influential?
(Suggest an Edit or Addition)According to Wikipedia, Cassandra Szoeke is an Australian medical researcher and practicing physician in internal medicine, with a sub-specialisation in neurology. Szoeke is the director of the Healthy Ageing Program at the University of Melbourne and principal investigator of the Women’s Healthy Ageing Project, which is the longest ongoing study of women's health in Australia.
Cassandra Szoeke's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2015) (4436)
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4388)
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (3308)
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (2141)
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1869)
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) (1718)
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study (2013) (1546)
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
- Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) (1485)
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1477)
- Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (1121)
- Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 (2017) (1090)
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging (2010) (950)
- Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (802)
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease (2011) (718)
- Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) (685)
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease (2009) (680)
- Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (623)
- Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (579)
- Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (538)
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (495)
- Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 (2016) (394)
- Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) (376)
- Blood-based protein biomarkers for diagnosis of Alzheimer disease. (2012) (354)
- Relationship between atrophy and β‐amyloid deposition in Alzheimer disease (2010) (354)
- Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort (2012) (290)
- Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017) (280)
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin (2013) (278)
- Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease (2013) (235)
- β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia (2010) (232)
- Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing (2013) (207)
- Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (2013) (198)
- Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study (2007) (189)
- Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. (2014) (183)
- Plasma apolipoprotein E and Alzheimer disease risk (2011) (182)
- Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients (2010) (154)
- Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study (2011) (153)
- Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease (2013) (151)
- Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population (2012) (147)
- Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. (2011) (142)
- Larger temporal volume in elderly with high versus low beta-amyloid deposition. (2010) (140)
- Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age (2013) (136)
- A Systematic Review and Meta‐Analysis of The Effect of Low Vitamin D on Cognition (2017) (125)
- Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. (2010) (125)
- Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease (2014) (121)
- Incidence of cerebral microbleeds in preclinical Alzheimer disease (2014) (120)
- Intense physical activity is associated with cognitive performance in the elderly (2012) (115)
- Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study (2012) (114)
- Effects of Anticholinergic Drugs on Cognitive Function in Older Australians: Results from the AIBL Study (2011) (112)
- Dietary patterns and cognitive decline in an Australian study of ageing (2014) (110)
- Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults (2012) (109)
- Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease (2014) (98)
- Factors affecting the prevalence of osteoarthritis in healthy middle-aged women: data from the longitudinal Melbourne Women's Midlife Health Project. (2006) (92)
- Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). (2013) (88)
- A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women (2009) (88)
- Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. (2011) (88)
- Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study (2017) (78)
- Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease (2014) (76)
- Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. (2014) (76)
- Update on pharmacogenetics in epilepsy: a brief review (2006) (73)
- Hormone levels and cognitive function in postmenopausal midlife women (2012) (67)
- Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease (2013) (66)
- Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987 (2013) (64)
- Diet and biomarkers of Alzheimer's disease: a systematic review and meta-analysis (2019) (63)
- Association of Plasma Aß Peptides with Blood Pressure in the Elderly (2011) (63)
- Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative (2010) (57)
- Sexual function in the late postmenopause: a decade of follow-up in a population-based cohort of Australian women. (2014) (55)
- The relationship between prospectively assessed body weight and physical activity and prevalence of radiological knee osteoarthritis in postmenopausal women. (2006) (54)
- Do replicable profiles of multimorbidity exist? Systematic review and synthesis (2019) (53)
- Rapid decline in episodic memory in healthy older adults with high amyloid-β. (2013) (53)
- Is grandparenting a form of social engagement that benefits cognition in ageing? (2015) (53)
- The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study (2008) (53)
- Aβ amyloid, cognition, and APOE genotype in healthy older adults (2013) (52)
- Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: The AIBL Active trial (2012) (45)
- Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. (2013) (42)
- The Effect of Intimate Partner Violence on the Physical Health and Health-Related Behaviors of Women: A Systematic Review of the Literature (2021) (42)
- Multidrug‐resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: Data from international pharmacogenetic cohorts (2009) (42)
- Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing (2011) (42)
- Boomerang families and failure-to-launch: Commentary on adult children living at home. (2016) (41)
- Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. (2015) (41)
- Impact of menopausal status on negative mood and depressive symptoms in a longitudinal sample spanning 20 years (2017) (40)
- Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review. (2019) (39)
- Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsy (2010) (36)
- Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) (2013) (36)
- Gender, marital status and longevity. (2017) (36)
- Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. (2013) (34)
- The impact of red and processed meat consumption on cardiovascular disease risk in women. (2016) (33)
- A decade of changes in brain volume and cognition (2019) (30)
- Objectively assessed physical activity and sedentary behavior and global cognitive function in older adults: a systematic review (2021) (30)
- Prehypertension in midlife is associated with worse cognition a decade later in middle-aged and older women. (2015) (30)
- Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study (2014) (30)
- Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease? (2013) (29)
- Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. (2013) (29)
- Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial (2020) (29)
- The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI (2013) (28)
- Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) (2017) (27)
- Role of grandparenting in postmenopausal women’s cognitive health: results from the Women’s Healthy Aging Project (2014) (27)
- Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 (2021) (26)
- The Mediterranean dietary pattern and depression risk: A systematic review (2019) (25)
- The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women (2018) (25)
- Vitamin D status is associated with executive function a decade later: Data from the Women's Healthy Ageing Project. (2018) (25)
- Physician diagnosed arthritis, reported arthritis and radiological non-axial osteoarthritis. (2008) (24)
- Pupil response biomarkers for early detection and monitoring of Alzheimer's disease. (2013) (23)
- Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases (2009) (22)
- The Women's Healthy Ageing Project: Fertile ground for investigation of healthy participants ‘at risk’ for dementia (2013) (21)
- Grandparenting predicts late-life cognition: Results from the Women's Healthy Ageing Project. (2015) (21)
- Research and standardization in Alzheimer's trials: Reaching international consensus (2013) (20)
- Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status (2014) (20)
- Dietary patterns and β-amyloid deposition in aging Australian women (2018) (19)
- Predictive Factors for Verbal Memory Performance Over Decades of Aging: Data from the Women's Healthy Ageing Project. (2016) (17)
- Additional structured physical activity does not improve walking in older people (>60years) undergoing inpatient rehabilitation: a randomised trial. (2018) (16)
- Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis. (2021) (16)
- COVID-19 vaccines: Considering sex differences in efficacy and safety (2022) (16)
- A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer’s Disease: The AIBL Active-Study (2018) (16)
- Incidence of Medication-Treated Depression and Anxiety Associated with Long-Term Cancer, Cardiovascular Disease, Diabetes and Osteoarthritis in Community-dwelling Women and Men (2019) (15)
- Association Between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline (2020) (15)
- Cohort profile: Women’s Healthy Ageing Project (WHAP) - a longitudinal prospective study of Australian women since 1990 (2016) (15)
- Executive functions in recently postmenopausal women: Absence of strong association with serum gonadal steroids (2011) (14)
- Hormone levels and cognitive function in postmenopausal midlife women (2012) (13)
- Relationship between Atrophy and Beta-Amyloid Deposition in Normal Elderly, Mild Cognitive Impairment and Alzheimer's Disease (2010) (12)
- Robust Norms for Neuropsychological Tests of Verbal Episodic Memory in Australian Women (2019) (12)
- Pharmacological Treatment of Frailty in the Elderly (2009) (12)
- Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy (2004) (12)
- Evaluating the effects of increasing physical activity to optimize rehabilitation outcomes in hospitalized older adults (MOVE Trial): study protocol for a randomized controlled trial (2015) (12)
- Adherence to the Mediterranean Diet Is not Related to Beta-Amyloid Deposition: Data from the Women’s Healthy Ageing Project (2018) (11)
- Semi‐automated hippocampal segmentation in people with cognitive impairment using an age appropriate template for registration (2015) (9)
- Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing. (2014) (9)
- Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women (2017) (9)
- The course of depressive symptoms during the postmenopause: a review (2015) (8)
- Survival in elderly men in relation to midlife and current BMI (2015) (8)
- Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults (2014) (8)
- Dehydroepiandrosterone sulfate and cognition in midlife, post-menopausal women (2014) (8)
- Verbal episodic memory is influenced by reported fatigue in otherwise healthy women: Data from the women’s healthy ageing project (2015) (7)
- Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer’s Disease (2020) (7)
- The trajectory of negative mood and depressive symptoms over two decades. (2017) (6)
- Patterns of social engagement in the transition to later life. (2016) (6)
- A comparison of Geriatric Depression Scale scores in older Australian and Japanese women (2016) (6)
- Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women. (2019) (6)
- Therapy of female sexual dysfunction. (2002) (6)
- Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority meta-analytical approach (2020) (6)
- Longitudinal nutritional changes in aging Australian women. (2019) (6)
- Advances in structural and molecular neuroimaging in Alzheimer's disease (2011) (6)
- Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease (2015) (6)
- Lifestyle and late life cognitive health: sufficient evidence to act now? (2012) (6)
- Association between structural changes in brain with muscle function in sarcopenic older women: the women’s healthy ageing project (WHAP) (2019) (6)
- Normative Data for the Tower of London Performance in Australian Midlife Women (2013) (5)
- Aβ amyloid, cognition and APOE genotype in the preclinical stages of Alzheimer's disease (2012) (5)
- Grand-parenting for healthy ageing in women: Fact or fiction? (2016) (5)
- A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls. (2022) (5)
- Self-reported confusion is related to global and regional β-amyloid: data from the Women’s healthy ageing project (2018) (5)
- Oestrogen Alpha-Receptor Variant and Two-Year Memory Decline in Midlife Australian Women (2012) (5)
- GRANDPARENTING IS ASSOCIATED WITH COGNITIVE FUNCTIONING IN OLDER WOMEN: RESULTS FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (4)
- Alzheimer's disease is associated with lower hemoglobin levels and anemia: The Australian Imaging Biomarker Lifestyle (AIBL) study of aging (2010) (4)
- The natural history of the dynamics of beta-amyloid deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease (2013) (4)
- Microbleeds and clinical trajectories: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging (2013) (4)
- Incidence, Progression, and Patterns of Multimorbidity in Community-Dwelling Middle-Aged Men and Women (2020) (4)
- NO GENDER DIFFERENCES IN RATES OF CONVERSION FROM COGNITIVELY HEALTHY TO MCI OR AD OVER 18 MONTHS: DATA FROM THE AIBL COHORT (2014) (4)
- A web‐based normative data tool for assessing cognitive performance in healthy older Australians (2011) (4)
- Beyond Sex Differences: A Spotlight on Women's Brain Health. (2021) (4)
- Sex hormones, vascular factors and cognition (2021) (4)
- Swimming pools in remote indigenous communities : some basic information for planning a pool (2000) (3)
- Predictors of cognitive decline at 18 month follow up among 1112 participants in the Australian imaging, biomarkers and lifestyle flagship study of ageing (AIBL) (2011) (3)
- Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition (2010) (3)
- Digital biomarkers and sex impacts in Alzheimer’s disease management — potential utility for innovative 3P medicine approach (2022) (3)
- Diet, neuroimaging biomarkers and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (2012) (2)
- Mid-life predictors of late-life depressive symptoms; determining risk factors spanning two decades in the Women’s Heathy Ageing Project (2020) (2)
- A surface based approach for cortical thickness comparison between PiB+ and PiB- healthy control subjects (2012) (2)
- Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months (2012) (2)
- Cognitive consequences of high beta-amyloid levels in people with mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease (2013) (2)
- THE ASSOCIATION BETWEEN AMYLOID BURDEN AND SUB-CLINICAL DEPRESSION IN HEALTHY OLDER ADULTS (2014) (2)
- Factors associated with improved walking in older people during hospital rehabilitation: secondary analysis of a randomized controlled trial (2021) (2)
- Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: A cross-sectional analysis (2011) (2)
- Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle study of Aging (AIBL) (2013) (2)
- Monitored physical activity is associated with better cognitive performance in the elderly: A study from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study (2010) (2)
- Alzheimer’s disease research progress in Australia: The Alzheimer’s Association International Conference Satellite Symposium in Sydney (2021) (2)
- The relationship between hassle severity, anxiety and cognitive performance: An 8-year follow-up in the Women's Healthy Aging Project (2013) (1)
- DOES ADDITIONAL PHYSICAL ACTIVITY IMPROVE WALKING IN OLDER PEOPLE DURING INPATIENT REHABILITATION (2017) (1)
- Reported memory complaints (2011) (1)
- Correction: Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women (2017) (1)
- The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers (2009) (1)
- IMPACT OF STATIN USE ON COGNITIVE DECLINE IN HEALTHY WOMEN FROM A LONG-TERM LONGITUDINAL SAMPLE (2017) (1)
- Stroke presenting under 3 hours in patients younger than 18 years of age (2009) (1)
- Performance of the different proposed criteria for the diagnosis of mild cognitive impairment and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle study of aging (2013) (1)
- The effect of vascular risk factors on cognition in older adults: Data from the AIBL study (2012) (1)
- Department of Error (2017) (1)
- Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) (2013) (1)
- Dependence and resource utilization in MCI and Alzheimer’s patients participating in the AIBL study (2011) (1)
- Investigating cardiovascular risk factors on cognition: A two-cohort study (2012) (1)
- Neuropsychological predictors of autobiographical memory impairment in mild cognitive impairment (MCI) (2013) (1)
- Correlation between white matter hyperintensities in MRI-FLAIR and 11C-PiB PET retention. A new potential for early identification of disease (2009) (1)
- Influence of Physical Activity Levels and Functional Capacity on Brain β-Amyloid Deposition in Older Women (2021) (1)
- Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease (2014) (1)
- The bimodality of healthy ageing: How do the differing profiles of healthy controls compare to patients with mild cognitive impairment? (2009) (1)
- Ten-year MRI changes and FBB-PET: Results from the Women's Healthy Aging Project (WHAP) (2013) (1)
- LONGITUDINAL COGNITIVE DECLINE IN THE AIPL COHORT: THE ROLE OF APOE ɛ4 STATUS (2014) (1)
- Determining rate of decline in pre-AD and AD AIBL participants using a brief computerized battery (2010) (1)
- Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study (2021) (1)
- Variability in mid-life high-density lipoprotein cholesterol (HDL-C) is related to poorer late-life episodic memory: The Women's Healthy Ageing Project (WHAP) (2012) (1)
- Secrets of Women's Healthy Ageing (2021) (0)
- The impact of hippocampal segmentation methods on correlations with clinical data (2019) (0)
- Establishing apolipoprotein J as a potential candidate for Alzheimer's disease biomarker panel: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of aging (2013) (0)
- The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment (2012) (0)
- Gene combination associations with Alzheimer's disease risk and quantitative traits in the AIBL study (2012) (0)
- Midlife vitamin d deficiency is associated with later-life depression in ageing women: data from the women’s healthy ageing project (whap) (2017) (0)
- SEX DIFFERENCES IN VASCULAR RISK FACTORS AND DEMENTIA: A SYSTEMATIC REVIEW AND META-ANALYSIS (2018) (0)
- Normative data from the AIBL study: Language, visuoconstruction, and executive functioning in a large healthy elderly cohort (2010) (0)
- Achieving physical activity guideline recommendation in older adults at risk of cognitive deterioration (2016) (0)
- MIDLIFE VASCULAR RISK, APOLIPOPROTEIN E-E4, AND AMYLOID STATUS 20 YEARS LATER: RESULTS FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
- THE SHORT- AND LONG-TERM EFFECTS OF A 24-MONTH HOME-BASED PHYSICAL ACTIVITY PROGRAM ON PHYSICAL ACTIVITY LEVELS AND BODY COMPOSITION OF OLDER ADULTS AT RISK OF ALZHEIMER’S DISEASE: THE AIBL ACTIVE TRIAL (2017) (0)
- SUBJECTIVE MEMORY COMPLAINTS TEN YEARS PRIOR HAVE NO RELATIONSHIP WITH BRAIN AMYLOID: DATA FROM THE WOMEN'S HEALTHY AGEING PROJECT (2014) (0)
- P1-071 INTENSITY OF DEMENTIATHROUGH LATENT VARIABLE MODELLING (I-DELV) IN THE AIBL COHORT (2019) (0)
- 449: Multidrug resistant (MDR1) genotype & seizure recurrence in newly treated epilepsy: Data from international prospective AED pharmacogenetic studies (2008) (0)
- Collaborating for a better future for Australians living with Alzheimer's disease (2013) (0)
- Effect of Aβ burden and apolipoprotein E-ε4 on cognitive decline at 18 months in healthy older adults (2012) (0)
- Hormones and dementia (2021) (0)
- In an amnestic MCI population, those with high PIB binding perform more poorly on memory tests than those with low binding (2010) (0)
- Healthy older adults in the AIBL cohort at risk for cognitive decline (2011) (0)
- ASSOCIATION BETWEEN LIPIDS, STATIN AND COGNITION: IS TIMING THE KEY? (2019) (0)
- Associatioin of Plasma Aβ Peptides with Blood Pressure in the Elderly (2020) (0)
- Brain structure in subjective cognitive decline: A replication study (2021) (0)
- The bimodality of healthy ageing: How do the differing profiles of healthy controls compare to patients with mild cognitive impairment? (2009) (0)
- Association between cardiovascular risk and cognitive measures among older adults at risk of cognitive decline (2016) (0)
- IN54-TH-01 Biomarkers for Alzheimer's disease from large cohort studies (2009) (0)
- AB018. Postmenopausal sexual functioning (2015) (0)
- EXPLORING THE RELATIONSHIP BETWEEN IQ AND OTHER COGNITIVE SCORES (2019) (0)
- Subjective memory complainers in the AIBL cohort: Hypervigilance amongst the worried well, or individuals at increased risk of Alzheimer's disease? (2010) (0)
- EVIDENCE OF AMYLOID ON FLORBETABEN-PET IS ASSOCIATED WITH REDUCED EPISODIC MEMORY 10 YEARS PRIOR: RESULTS FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
- Level of physical activity is associated with hippocampal volume in a subgroup of the AIBL cohort (2012) (0)
- The effect of vascular risk factors on the rate of cognitive change in older adults: Data from the Australian Imaging Biomarkers and Lifestyle (AIBL) flagship study (2013) (0)
- Effects of partial volume correction on the analysis of 11C-PiB PET in assessing Alzheimer's disease (2010) (0)
- Plasma levels of homocysteine and red cell folate correlate with neurological composite z-scores in Alzheimer's disease and healthy subjects: The Australian Imaging Biomarker Lifestyle (AIBL) study of aging (2010) (0)
- Midlife vascular risk and late-life amyloid burden: Data from the Women's Healthy Ageing Project (WHAP) (2013) (0)
- INCREASED P-GLYCOPROTEIN LEVEL IN RESECTED TEMPORAL NEOCORTEX CORRELATES WITH ONGOING PHARMACORESISTANT SEIZURES IN PATIENTS WITH MESIAL TEMPORAL LOBE EPILEPSY (2008) (0)
- ASSOCIATION BETWEEN ESR1 AND COGNITION IN ADNI COHORT (2019) (0)
- Association Between Testosterone and Cardiovascular Risk Across the Menopausal Transition (2016) (0)
- Findings from the first 18-month follow up of the Australian Imaging Biomarkers and Lifestyle (AIBL) cohort (2010) (0)
- Cerebral microbleeds, brain beta-amyloid and clinical trajectories: results from the AIBL study of ageing (2013) (0)
- Associations between gonadotropins, testosterone, plasma Aβ and PiB retention in men with subjective memory complaints or mild cognitive impairment (2010) (0)
- ASSOCIATION BETWEEN VITAMIN D, WMH, SUVR AND EXECUTIVE FUNCTION (2019) (0)
- An update on an AIBL blood-based biomarker panel for the prediction of Aβ burden (2012) (0)
- APOE and cognitive dysfunction in Alzheimer's dementia and mild cognitive impairment (2012) (0)
- DHEAS and cognitive function in post-menopausal women: The Women's Healthy Aging Study (2012) (0)
- What's the future of treatment for Alzheimer's disease? (2010) (0)
- Association of plasma Amyloid Beta peptides with blood pressure in the elderly (2011) (0)
- MULTIMORBIDITY DEFINED BY TRAJECTORIES OF CARDIOMETABOLIC MARKERS AND FOLLOWING COGNITIVE DECLINE OVER ONE DECADE: FINDINGS FROM THE WOMEN’S HEALTHY AGEING PROJECT (2019) (0)
- The influence of midlife cholesterol on late-life cognition: The Women's Healthy Ageing Project (WHAP) (2012) (0)
- MIDLIFE DYSLIPIDEMIA COMBINED WITH THE PRESENCE OF APOE-ε4 IS ASSOCIATED WITH AN INCREASED RISK OF LATE-LIFE CEREBRAL AMYLOID-BETA (2018) (0)
- Gender differences in the relationship between Aβ burden and memory (2010) (0)
- HIPPOCAMPAL VOLUMES IN SUBJECTS AT RISK OF ALZHEIMER ' S DISEASE WITH A NEW REGISTRATION TEMPLATE (2012) (0)
- Cognitive assessments as estimators of neocortical beta-amyloid burden in the AIBL cohort (2012) (0)
- Analysis of Peripheral Blood Biomarkers: Towards the Early Diagnosis Alzheimer's Disease (2010) (0)
- QUALITATIVE THEMATIC ANALYSIS OF SUBJECTIVE MEMORY COMPLAINTS IN THE HEALTHY ELDERLY AND INDIVIDUALS WITH MCI (2014) (0)
- The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers (2009) (0)
- Baseline and follow-up neuroimaging results from the Australian imaging, biomarker, and lifestyle flagship study of aging (AIBL) (2010) (0)
- The Women’s Healthy Ageing Project: A pattern of cognitive decline after brain injury (2021) (0)
- Linkage analysis of a family with familial partial epilepsy with variable foci (2004) (0)
- BIOMARKERS OF ALZHEIMER’S DISEASE AND DIET: A SYSTEMATIC REVIEW (2018) (0)
- MIDLIFE VASCULAR RISK, APOLIPOPROTEIN E-E4, AND AMYLOID STATUS 20 YEARS LATER: RESULTS FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
- Mood and Cognition in Aging Women (2016) (0)
- CAN OLDER ADULTS AT RISK OF ALZHEIMER’S DISEASE ADHERE TO A 24-MONTH HOME-BASED PHYSICAL ACTIVITY PROGRAM? THE AIBL ACTIVE–TRIAL (2017) (0)
- Associations of physical activity, body mass index and cardiovascular risk in older Australian women (2017) (0)
- Cognition in healthy older women is a predictor of 14‐year falls risk (2021) (0)
- A return to clinical skills in the early diagnosis of Alzheimer's disease (2012) (0)
- A decade of changes in brain volume and cognition (2018) (0)
- Change in cognition over 36 months in relation to blood biomarkers (2013) (0)
- Effects of a physical activity intervention on brain atrophy in older adults at risk of dementia: a randomized controlled trial (2021) (0)
- The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women (2018) (0)
- Contents Vol. 66, 2012 (2012) (0)
- PARTICIPANTS WHO REFUSE PET SCAN HAD SIGNIFICANTLY LOWER EPISODIC MEMORY THAN THOSE WHO CONSENTED TO SCAN: DATA FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
- Association of BMI and change in BMI with cognitive function, change in cognitive function and conversion to Alzheimer's disease (2013) (0)
- PARTICIPANTS WITH A POSITIVE AMYLOID SCAN IN THE WOMEN’S HEALTHY AGEING PROJECT HAD SIGNIFICANTLY WORSE EPISODIC MEMORY THAN THOSE WITH A NEGATIVE SCAN (2014) (0)
- Those with a family history of dementia were less likely to opt for an amyloid brain scan - Data from the Women’s Healthy Ageing Project (2014) (0)
- APOLIPOPROTEIN E4 GENE PREDICTS CHANGES IN EPISODIC MEMORY FROM MIDLIFE TO LATE-LIFE: DATA FROM THE WOMEN’S HEALTHY AGEING PROJECT (WHAP) (2014) (0)
- A SIMPLE TEST OF EPISODIC MEMORY PREDICTS CONVERSION TO DISEASE (MCI/AD) A DECADE LATER: DATA FROM THE WOMEN’S HEALTHY AGEING PROJECT (WHAP) (2014) (0)
- A simple test of episodic memory predicts conversion to disease (MCI/AD) aÂÃââ'¬Å¡Ãƒâ€šÃ' decade later: data from the women's healthy ageing project (WHAP) (2014) (0)
- Predictive factors for verbal memory performance over decades of ageing: Data from the Women’s (2016) (0)
- EVIDENCE OF AMYLOID ON FLORBETABEN-PET IS ASSOCIATED WITH REDUCED EPISODIC MEMORY 10 YEARS PRIOR: RESULTS FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
- Incidence and associations of lobar microbleeds: Results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (AIBL) (2012) (0)
- REPORTED EPISODES OF CONFUSION IN HEALTHY PARTICIPANTS HAVE A RELATIONSHIP WITH CEREBRAL AMYLOID LOAD: DATA FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
- Correlation between white matter hyperintensities in MRI-FLAIR and 11C-PiB PET retention: A new potential for early identification of disease (2009) (0)
- AIBL ACTIVE: A randomized controlled trial of physical activity to delay the progression of white matter hyperintensities on MRI in older adults at risk of cognitive decline (2012) (0)
- Modulation of Amyloid Beta (Aβ) Structure and Toxicity by a Dairy-derived Peptide Product (2010) (0)
- Incidence ofMedication-Treated Depression andAnxiety Associatedwith Long-TermCancer, Cardiovascular Disease, Diabetes andOsteoarthritis in Community-dwelling Women and Men (2019) (0)
- Beta-amyloid and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease (2013) (0)
- P1–148: Withdrawn (2013) (0)
- IDENTIFYING ELDERS AT RISK FOR COGNITIVE DECLINE USING THE BRAIN HEALTH REGISTRY (BHR) (2019) (0)
- IMPACT ON COGNITION IN PERSONS WITH NORMAL COGNITION, MCI, AND DEMENTIA (2014) (0)
- Identifying protein biomarkers for early diagnosis of Alzheimer's disease (2010) (0)
- BRAIN BETA-AMYLOID, VASCULAR FACTORS, AND COGNITION: 54-MONTH FOLLOWUP RESULTS FROM THE AIPL STUDY (2014) (0)
- Vascular Cognitive Disorder (2009) (0)
- Identification of heterogeneity in the cognitive functioning of AIBL healthy controls (2011) (0)
- Pharmacogenetics in epilepsy: An Australian prospective study (2005) (0)
- THE AUSTRALIAN BRAIN HEALTH REGISTRY-HEALTHY BRAIN INITIATIVE (2019) (0)
- Relationship between cerebral amyloid angiopathy and white matter hyperintensities in demented and nondemented subjects (2011) (0)
- MENOPAUSE AND COGNITION (2019) (0)
- BRAIN BETA-AMYLOID, VASCULAR FACTORS, AND COGNITION: 54-MONTH FOLLOWUP RESULTS FROM THE AIPL STUDY (2014) (0)
- A MULTI-SNP PREDICTOR FOR DRUG OUTCOME IN COMPLEX DISEASES (2008) (0)
- Alzheimer's disease-related changes in plasma brain-derived neurotrophic factor levels: Data from the AIBL study (2012) (0)
- Clinical utility of the cogstate brief battery in Alzheimer's disease–related memory impairment (2013) (0)
- Subjective Memory Complaints and Cognitive Tests in the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) (2011) (0)
- Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study (2012) (0)
- Longitudinal change in cognition in two classes of healthy controls from the AIBL study (2012) (0)
- Biomarkers for risk of Alzheimer's disease: Modeling the severity of neurofibrillary tangles in the Hippocampus region (2010) (0)
- Corrigendum to "The trajectory of negative mood and depressive symptoms over two decades" [Maturitas 95 (2017) 36-41]. (2017) (0)
- Self-reported confusion is related to global and regional β-amyloid: data from the Women’s healthy ageing project (2017) (0)
- Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing (2012) (0)
- Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease (2013) (0)
- SUBJECTIVE MEMORY COMPLAINTS TEN YEARS PRIOR HAVE NO RELATIONSHIP WITH BRAIN AMYLOID: DATA FROM THE WOMEN’S HEALTHY AGEING PROJECT (2014) (0)
This paper list is powered by the following services:
Other Resources About Cassandra Szoeke
What Schools Are Affiliated With Cassandra Szoeke?
Cassandra Szoeke is affiliated with the following schools:
